PCV114 FEASIBILITY OF USING REAL WORLD EVIDENCE TO INFORM DECISIONS ON CONDUCTING A COST EFFECTIVENESS ANALYSIS: AN EXAMPLE OF STROKE RISK REDUCTION THERAPIES IN ATRIAL FIBRILLATION
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.838
https://www.valueinhealthjournal.com/article/S1098-3015(19)33216-4/fulltext
Section Title :
Section Order :
10737
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33216-4&doi=10.1016/j.jval.2019.09.838